Undervalued Small Caps With Insider Action In US For December 2024

In This Article:

Over the last 7 days, the United States market has experienced a slight decline of 1.1%, yet it remains robust with a 22% increase over the past year and an anticipated annual earnings growth of 15%. In this context, identifying small-cap stocks that are perceived as undervalued and have insider action can be particularly appealing to investors looking for potential opportunities amidst fluctuating market dynamics.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name

PE

PS

Discount to Fair Value

Value Rating

OptimizeRx

NA

1.1x

45.15%

★★★★★☆

German American Bancorp

14.7x

4.9x

45.91%

★★★★☆☆

Quanex Building Products

34.2x

0.9x

38.49%

★★★★☆☆

Franklin Financial Services

9.4x

1.9x

40.80%

★★★★☆☆

McEwen Mining

3.9x

2.0x

49.41%

★★★★☆☆

ProPetro Holding

NA

0.6x

37.82%

★★★★☆☆

Douglas Dynamics

10.0x

1.0x

-9.64%

★★★☆☆☆

ChromaDex

280.9x

4.6x

35.36%

★★★☆☆☆

First United

13.5x

3.1x

47.84%

★★★☆☆☆

Community West Bancshares

18.7x

2.9x

42.25%

★★★☆☆☆

Click here to see the full list of 51 stocks from our Undervalued US Small Caps With Insider Buying screener.

We're going to check out a few of the best picks from our screener tool.

Semler Scientific

Simply Wall St Value Rating: ★★★★☆☆

Overview: Semler Scientific is a company that develops, manufactures, and markets diagnostic kits and equipment, with a market capitalization of $0.23 billion.

Operations: The company generates revenue primarily from diagnostic kits and equipment, with recent quarterly revenue reaching $58.94 million. Over the years, it has seen fluctuations in its gross profit margin, which was 88.05% most recently. Operating expenses are notable, with significant allocations towards sales and marketing as well as research and development activities.

PE: 29.3x

Semler Scientific, a small company in the U.S., has drawn attention for its insider confidence. Eric Semler purchased 50,000 shares worth US$1.9 million, increasing their stake by nearly 9%. Despite recent volatility and reliance on external borrowing, the company reported Q3 net income of US$5.6 million against last year's US$5.5 million. However, sales fell to US$13.51 million from US$16.32 million year-over-year, highlighting potential challenges ahead amidst growth opportunities in healthcare technology solutions.

NasdaqCM:SMLR Share price vs Value as at Dec 2024
NasdaqCM:SMLR Share price vs Value as at Dec 2024

Myers Industries

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Myers Industries operates in the distribution and material handling sectors, with a market cap of approximately $0.76 billion.